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The adrenoleukodystrophy protein (ALDP) and the 70-kDa
peroxisomalmembrane protein (PMP70) are half-ATP-binding
cassette (ABC) transporters in the mammalian peroxisome
membrane. Mutations in the gene encoding ALDP result in a
devastating neurodegenerative disorder, X-linked adrenoleu-
kodystrophy (X-ALD) that is associated with elevated levels of
very long chain fatty acids because of impaired peroxisomal
-oxidation.The interactions of peroxisomalABC transporters,
their role in the peroxisomal membrane, and their functions in
disease pathogenesis are poorly understood. Studies on ABC
transporters revealed that half-transporters have to dimerize to
gain functionality. So far, conflicting observations are described
for ALDP. By the use of in vitromethods (yeast two-hybrid and
immunoprecipitation assays) on the one hand, it was shown that
ALDP can form homodimers as well as heterodimers with
PMP70 and ALDR, while on the other hand, it was demon-
strated that ALDP and PMP70 exclusively homodimerize. To
circumvent the problems of artificial interactions due to bio-
chemical sample preparation in vitro, we investigated protein-
protein interaction of ALDP in its physiological environment by
FRETmicroscopy in intact living cells. The statistical relevance
of FRET data was determined in two different ways using prob-
ability distribution shift analysis and Kolmogorov-Smirnov sta-
tistics. We demonstrate in vivo that ALDP and PMP70 form
homodimers as well as ALDP/PMP70 heterodimers where
ALDP homodimers predominate. Using C-terminal deletion
constructs of ALDP, we demonstrate that the last 87 C-terminal
amino acids harbor the most important protein domain medi-
ating these interactions, and that the N-terminal transmem-
brane region of ALDP has an additional stabilization effect on
ALDPhomodimers. Loss ofALDPhomo-orheterodimerization
is highly relevant for understanding the disease mechanisms of
X-ALD.
The adrenoleukodystrophy protein (ALDP,2 ABCD1) is a
member of the ATP-binding cassette (ABC) transporter pro-
tein family, and one of four ABC transporters in the mamma-
lian peroxisomal membrane. The other members are the adre-
noleukodystrophy-related protein (ALDR, ABCD2), the
70-kDa peroxisomal membrane protein (PMP70, ABCD3), and
the PMP70-related protein (P70R/PMP69, ABCD4) (1–6).
Mutations in the gene encoding ALDP cause X-linked adre-
noleukodystrophy (X-ALD), the most common inherited per-
oxisomal disorder that is characterized by the abnormal accu-
mulation of saturated very long chain fatty acids (VLCFAs)
predominantly in brain white matter, adrenal cortex, and testis
(7–10). The clinical phenotype is highly variable ranging from
the devastating childhood cerebral form with progressive
demyelination to the existence of asymptomatic individuals.
The pathogenesis of X-ALDand especially the exact function of
peroxisomal ABC transporters in the disease process are still
completely unknown. ALDP and the other peroxisomal ABC
transporters may be involved in the import of VLCFAs or acti-
vated fatty acids across the peroxisomal membrane into the
peroxisomal lumen for degradation (11, 12) as described for the
yeast peroxisomal ABC homologs Pxa1 and Pxa2 also called
Pat1 and Pat2 (13, 14).
Localization of the ABC transporters to the peroxisomal
membrane is mediated by Pex19p (15, 16). The known target-
ing motif for peroxisomal localization is at the N-terminal part
of ABC transporters. For ALDP AA68–82 function as binding
site for Pex19p. In addition, twomembrane domains are neces-
sary for correct intracellular localization (17, 16). AA 1–124 are
required for peroxisomal localization of PMP70, and the bind-
ing site for Pex19p is included in the first 60 AA (18, 19, 20).
ABC transporters generally consist of two homologous
halves, each containing a membrane-spanning domain with
multiple hydrophobic transmembrane helices and a hydro-
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philic cytosolic nucleotide binding fold (NBF) (21). The NBF
contains the highly conserved motifs Walker A, Walker B and
19-mer that are important for substrate specificity and nucleo-
tide binding (22, 23). ABC transporters can either be found as
complete full-size transporters comprising twelve transmem-
brane helices and two NBFs, or as half transporters comprising
six transmembrane helices and a single NBF. Themultiple drug
resistance transporter (MDR) (24) and the cystic fibrosis trans-
membrane regulator (CFTR) (25) are exemplars for the former,
and TAP1 and TAP2 proteins (26) for the latter. All four mam-
malian peroxisomal ABC transporters known to date belong to
the group of ABC half-transporters and thus form obligate
homodimers or heterodimers to attain functionality (27). So
far, in vitro studies for dimerization of peroxisomal ABC trans-
porters have given inconsistent observations. Investigations by
three different groups using yeast two-hybrid and co-immuno-
precipitation experiments revealed that human ALDP could
form either homodimers or heterodimers with PMP70 and
ALDR (28–30). These results could not be confirmed by a fur-
ther investigation using immunoprecipitated ALDP and
PMP70 complexes from digitonin-solubilized mouse liver per-
oxisomes; ALDP as well as PMP70 could only be detected as
homomeric proteins and not in heteromeric association (31).
To further elucidate the interaction of ABC transporters in
the peroxisomal membrane and especially the formation of
homo- or heterodimers for human ALDP and PMP70, we
applied FRET microscopy in intact living cells, a method that
avoids artificial alterations due to biochemical sample prepara-
tion prior to analysis. In addition, we generated various ALDP
deletion constructs to identify the protein domains that medi-
ate ALDP dimerization.
EXPERIMENTAL PROCEDURES
Plasmid Constructions—All oligonucleotides used for plas-
mids constructions are listed in Table 1. The cDNA fragments
encodingALDP, ALDP390 (AA1 toAA390), ALDP550 (AA1 to
AA550), ALDP658 (AA1 toAA658), ALDP551–657 (residues
551–657 were deleted), and ALDPNBF (residues 391–657
were deleted) (Fig. 1) were amplified from RZPD clone
IRAKp961 0514Q2 (Deutsches Ressourcenzentrum fu¨r Genom-
forschungGmbH, Berlin) by PCR. Amplification products were
cloned into pECFP-N1, pEYFP-N1, or pECFP-C1 vectors
(Clontech) via the corresponding restriction enzymes. The stop
codon was deleted from the ALDP constructs by site-directed
mutagenesis using the site-directed mutagenesis kit (Strat-
agene) and the oligonucleotides “ALDP-EYFP-N1-Mut for”
and “ALDP-EYFP-N1-Mut rev.” ALDP551–657 was con-
structed as follows: the C-terminal part of ALDP (AA658-
AA745) was amplified using the oligonucleotide pair “ALDP
down” and “ALDPdel551–657”. The PciI restriction site inside
the vectors of theALDP658-ECFP-N1 andALDP658-EYFP-N1
constructs was disrupted by site-directed mutagenesis using
oligonucleotides “Mut-PciI for” and “Mut-PciI rev”. Digestion
of these constructs with PciI andHindIII resulted in the AA1 to
AA551 fragment to which the C-terminal part of ALDP
(AA658-AA745) was ligated leading to ALDP missing residues
551 to 657 (Fig. 1). The stop codons were deleted by site-di-
rected mutagenesis PCR with oligonucleotides “ALDP-Stop-
Del for” and “ALDP-Stop-Del rev”. For the ALDPNBF con-
structs AA 391 to AA 657 were deleted. Therefore, ALDP390
constructs were linearized by HindIII and ligated with the
C-terminal part of ALDP (AA658 to AA745) amplified with
oligonucleotides ALDPdelNBF and ALDPdown without Stop
by PCR. PMP70was amplified from total human cDNAby PCR
using oligonucleotides “PMP70-N1 up” and “PMP70-N1
down.” The amplified product was cloned into vectors
pECFP-N1 and pEYFP-N1 via the appropriate restriction sites.
Pex26, a peroxisomal single transmembrane protein with its N
terminus exposed to the cytosol, was amplified from the con-
structs described by Weller et al. (32) using the oligonucleo-
tides “Pex26 for” and “Pex26 rev” and subsequently cloned into
vector pECFP-C1. All PCR amplifications except for the
mutagenesis were performed using the BDAdvantageTM2PCR
kit (Clontech) according to the manufacturer’s recommenda-
tions. The identity of all constructs was verified by sequence
analysis.
Cell Culture and Electroporation—Either CHO cells ormon-
key cells are often used for peroxisomal studies. Because an
efficient electroporation protocol for VERO cells was estab-
TABLE 1
Oligonucleotide sequences used for construction of plasmids
Oligonucleotide sequences are shown from 5- to 3-end. Restriction sites in the sequence of the cloning oligonucleotides are shown in italics and restriction enzymes are
listed.
Name Sequence (5–3) Restriction enzyme
ALDP up ttactcgagcaatgccggtgctctccaggccccgg XhoI
ALDP down tttaagctttcaggtggaggcaccctggaggcc HindIII
ALDP390 down tttaagcttgttgcgggcaatagtgaaggc Hin III
ALDP550 down tttaagcttcacagacatgtagggcctctgcg HindIII
ALDP658 down tttaagcttggtgatggagagcagggcaatgc HindIII
ALDPdel551–657 aatacatgtctcaccggccctccctgtggaa PciI
ALDPdelNBF attaagcttcaccggccctccctgtggaa HindIII





Mut-Pci I for Gccttttgctcacttgttctttcctgc
Mut-Pci I rev gcaggaaagaacaagtgagcaaaaggc
PMP70-N1 up taactcgagatggcggccttcagcaagtacttg XhoI
PMP70-N1 down ttaggatcctgagagccaaactcaactgtatc BamHI
Pex26 for Ttactcgagcaatgaagagcgattcttcg XhoI
Pex26 rev Ttagaattctcagtcacggatgcggagc EcoRI
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lished in our laboratories, we used these cells for the experi-
ments. For cell culture, Vero cells (African green monkey kid-
ney cells, ECACC 84113001) were grown in Dulbeccos
modified Eagle’s medium (Cambrex) supplemented with 2 mM
glutamine, 10% (v/v) heat-inactivated fetal calf serum, 100
units/ml penicillin, 0.1 mg/ml streptomycin at 37 °C and 10%
CO2. At the time of confluency, cells were harvested by
trypsinization, washed with phosphate-buffered saline and
resuspended in 300 l of cytomix (120 mM KCl, 10 mM
KH2PO4, 10 mM K2HPO4, 2 mM EGTA, 5 mM MgCl2, 25 mM
HEPES, 0.15 mM CaCl2, 5 mM GSH, and 2 mM ATP pH7.4)
containing 10 to 15 g of each DNA coding for the indicated
proteins. Immediately thereafter cells were transfected by elec-
troporation (Gene Pulser II, Bio-Rad, pulse 0.7 kV, 50 F, 1–2
ms) and grown until the experiment.
Live Cell FRET Microscopy Experiments—For single cell
FRET experiments, CFP and YFP were used as donor and
acceptor fluorescent molecules, respectively. FRET measure-
ments were performed 24 h after electroporation using an
inverted microscope (Axiovert200, Zeiss). To minimize
organelle movement, cells were cooled down on ice in cold
medium prior to measurement. Tominimize background fluo-
rescence, themediumHAM’s F-12without phenol red (Promo-
Cell) was used. CFP was detected using a filter set composed of
an excitation filter 436/20 nm, a dichroic beam splitter 455 nm
and an emission filter 480/40 nm. For YFP an excitation filter
500/20 nm, a dichroic beam splitter 515 nm and an emission
filter 535/30 nm were used. The FRET filter set consisted of an
excitation filter 436/20 nm, a dichroic
beamsplitter 455nmandanemission
filter 535/30 nm. Images were
acquired using a cooled charge-cou-
pled device camera and the Meta-
morph 6 software (Universal Imaging
CorporationWest Chester).
Image Analysis—All image proc-
essing was performed using ImageJ.
Images were registered for stage
translation between acquisitions
using the “TurboReg” plugin (P.
The´venaz, Swiss Federal Institute of
Technology, Lausanne) converted to
32 bit, binned 2 2, and subjected to
a median filter with kernel size 0.5.
The YFP image intensities were
matched to the exposure time of the
CFP and FRET images. Background
fluorescence was estimated from an
area free of cells and subtracted. The
spectrally corrected FRET ratio was
calculated by Equation 1,
FRET ratio

FRET a CFP b YFP
CFP YFP
(Eq. 1)
where a and b represent correction factors for YFP and CFP
bleed-through emissions into the FRET images, respectively.
Note that the equation normalizes the FRET signals to the
expression levels of the fluorescent proteins (33). The resulting
corrected FRET ratio was multiplied by a digital mask that was
generated from an intensity-threshold YFP image of the same
sample to remove noise generated by low-intensity regions. All
further calculations were performed using the Igor Pro suite
(Wavemetrics Inc. Portland, OR). FRET ratio distribution his-
tograms were generated and normalized to unity. Cumulative
histograms of experiments on the same conditionswere re-nor-
malized to unity to obtain probability density functions (PDF).
The PDF of the negative control Pex26 co-expressed with
ALDPwas fitted with a Gaussian function to obtain the value of
themean 3 the standard deviation (3), corresponding to a
FRET ratio of 0.215. For each cell, the probability of exceeding
this 3 threshold, i.e. the probability of obtaining FRET ratios
higher than contained in the negative control, was obtained by
integration of the PDF above the 3 threshold. Themean prob-
ability value for all conditions and their standard error on the
mean (S.E.) was subjected to one-way analysis of variance with
pair-wise Tukey post-doc testing for statistical significance.
The PDFs were also subjected to statistical testing using the
Kolmogorov-Smirnov method that takes into account changes
over the entire distribution of FRET ratios per condition. The
PDFs were integrated to obtain cumulative density functions
(CDFs), and the pair-wise probability for statistically significant
differences between conditions was calculated from the CDFs
FIGURE 1. Scheme of ALDP constructs used for FRET experiments. ALDP constructs used for FRET experi-
ments are shown. The orange color represents the transmembrane domains (TMDs) consisting of six mem-
brane-passing segments. The Walker A motif (A), the 19-mer sequence (19-mer) also called C-region and the
Walker Bmotif (B) of the NBF are illustrated in yellow. Numbersmark amino acid positions. ALDP658, ALDP550,
andALDP390are truncatedat theC terminus. InALDP551–657 the internal aminoacids 551–657aredeleted,
while in ALDPNBF amino acids 391–657 are deleted. , , and  indicate low, moderate, and high
FRET, respectively.
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using the statistical package of the MatLab suite (The Math-
works, Inc. Natick, MA).
Representative examples of the FRET ratio for different con-
ditions are represented in an intensity-weighed color lookup
table where color saturation varies in accordance with the flu-
orescence intensity of the YFP image.
Comparison of Protein Expression Levels—Expression levels
of ALDP and PMP70 were measured by means of fluorescence
microscopy on a cell-by-cell basis (38). Cells were transfected
with either ALDP-ECFP-N1 or PMP70-ECFP-N1. 24 h after
transfection, cells were fixed and stained with either ALDP
antibody (ALD-1D6-As or ALD-2B4-As, Euromedex), or
PMP70 antibody (kindly provided by Wilhelm Just, Heidel-
berg). Corresponding Cy3-labeled secondary antibodies were
used for visualization (Jackson Laboratories). Intensity differ-
ences between transfected (as judged by CFP fluorescence) and
untransfected cells were used to determine the relative overex-
pression level of ALDP or PMP70 (endogenous and transfected





where f is the fold overexpression relative to endogenous protein,
and I and I0 represent the staining intensities of transfected and




and of PMP70 with PMP70—
Because ALDP and PMP70 can only
function upon dimerization, we
performed FRET measurements in
living cells to assess potential inter-
actions in vivo. To determine
whether ALDP and PMP70 can
form heterodimers as described by
Liu et al. (1999) or function exclu-
sively as a homomeric protein unit
as proposed by Guimara˜es et al.
(31), we transfected Vero cells with
ALDP-EYFP and co-expressed
ALDP-ECFP or PMP70-ECFP or
transfected cells with PMP70-ECFP
and co-expressed PMP70-EYFP. As
a negative control, we co-expressed
Pex26-ECFP, a peroxisomal mem-
brane protein with a single trans-
membrane domain that is not
related to ABC transporters (34).
The proper peroxisomal localiza-
tion of the fluorescently tagged
proteins was verified by single
transfection of each construct
together with ECFP-SKL or EYFP-
SKL, a well established fluorescent
peroxisomal marker (data not
shown). Because the peroxisomal tar-
geting signal forABCtransporters is locatedat theN-terminalpart
while the EYFP/ECFP is located at the C terminus, the tag did not
influence localization. In addition, expression of full-length pro-
teins was verified byWestern blot analysis (data not shown).
Functionality of the proteins is not impaired by fluorescent
protein fusion as shown by ALDR-EGFP that is able to rescue
the C26:0 -oxidation in X-ALD fibroblasts (35).
Fig. 2 shows the peroxisomal localization of the FRET accep-
tors ALDP-EYFP and PMP70-EYFP. The respective CFP-la-
beled donor protein revealed complete co-localization (data
not shown). The FRET ratios of the expression combinations
ALDP-EYFP/ALDP-ECFP, ALDP-EYFP/Pex26-ECFP, ALDP-
EYFP/PMP70-ECFP, and PMP70-EYFP/PMP70-ECFP of rep-
resentative cells 20 to 24 h after transfection are exemplarily
shown. The FRET ratio is represented in false colors ranging
from blue (low FRET) via white to red (high FRET). Cells co-
expressing ALDP-EYFP and ALDP-ECFP show strong FRET
with an overall ratio of 0.3 (Fig. 2, left lower panel) indicative of
efficient homodimerization. The FRET ratio is homogeneously
distributed over peroxisomes in the cell. In contrast, co-expres-
sion of ALDP-EYFP and Pex26-ECFP does not reveal signifi-
cant FRET, confirming that ALDP does not interact with per-
oxisomal membrane proteins in general, and thus the
applicability of Pex26 as a negative control. The FRET ratios are
homogeneously low (ratio 0.05; Fig. 2, lower left middle
FIGURE 2. ALDP and PMP70 homodimerization and ALDP/PMP70 heterodimerization. The upper panel
shows the fluorescence distribution of ALDP-EYFP in peroxisomes of cells that co-express CFP-labeled ALDP,
Pex26, and PMP70 (left three images). The localization of the CFP-labeled protein is identical to that of ALDP-
EYFP (not shown). The right image shows the fluorescence distribution of PMP70-EYFP. Again this signal per-
fectly co-localizes with the co-expressed PMP70-ECFP. The interaction of the CFP-labeled proteins with ALDP-
EYFP (left three images) or the homodimerization between EYFP- and ECFP-labeled PMP70 (right image), as
judged by the presence of FRET is shown in the lower panel (for the calculation of the FRET ratio see “Experi-
mental Procedures.” The FRET ratio is shown in false color ranging from blue (low FRET), viawhite (intermediate
FRET) to red (high FRET). Color saturation is weighed by the fluorescence intensity of ALDP-EYFP (left three
images) or PMP70-EYFP (right image), dark colors correspond to dim structures and full colors to bright
structures.
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panel). Co-expression of ALDP-
EYFP and PMP70-ECFP results in
intermediate FRET with an overall
ratio of 0.15 (Fig. 2, lower right mid-
dle panel). Intermediate FRET can
also be seen in cells expressing
PMP70-ECFP and PMP70-EYFP.
The ratio for these constructs is 0.15
(Fig. 2, lower right panel). These data
are indicative of the heterodimeriza-
tion of ALDP and PMP70 and of
PMP70 homodimerization, respec-
tively. Although the ratio is lower
than that obtained for co-expression
ofALDPwith itself, it is clearly higher
than that obtained for ALDP co-ex-
pression with Pex26.
We further confirmed the extent
of the revealed protein-protein
interactions by quantitative statisti-
cal analysis in two different ways.
First, using a recently published
method (36) suitable for non-Gaus-
sian distributions. Briefly, from the
distribution of FRET ratios for the
negative control situation ALDP/
Pex26, an upper FRET ratio thresh-
old was determined that could still
be statistically attributed to the
absence of FRET. This threshold
was derived by Gaussian fitting of
the ALDP/Pex26 distribution, fol-
lowedby the calculation of themean
ratio plus three times the standard
deviation. This value corresponded
to a FRET ratio of 0.215 and was
used as reference for all other FRET
measurements. The occurrence of
FRET in cells was defined as a signif-
icant increase in the probability of
exceeding this threshold, namely in
obtaining values larger than 0.215.
This probability can be estimated by
normalization of the integral of the
FRET ratio distribution of each cell
to unity (yielding the so-called
probability density function, PDF).
The integral of the PDFbins exceed-
ing the threshold represents the
probability of detecting significant
FRET. By performing this analysis
on 15 ALDP/Pex26, 10 ALDP/
PMP70, 15 ALDP/ALDP, and 11
PMP70/PMP70 co-expressing cells,
the mean probability and its stand-
ard error on themeanwas obtained.
The results are shown in the first
four bars of panel E in Fig. 3. The
FIGURE 3.Statistical analysis of protein-protein interactions analyzedbyFRETmicroscopy.A, cumulative
normalized and weighed FRET ratio distributions (probability density functions, PDF) of the interaction
betweenALDP-EYFPandCFP-labeledALDP (red trace,n15 cells), Pex26 (black trace,n15), andPMP70 (blue
trace, n  10), and between PMP70-EYFP and PMP70-ECFP (purple trace, 11 cells) as shown in Fig. 2. The
threshold for the detection of FRET, i.e. the average plus three times the standard deviation of ALDP-Pex26
interaction is indicated by a dashed line (3, equal to a FRET ratio of 0.215). B, integrated PDFs, the cumulative
density function (CDF), of panel Ausing the same color-coding for the different conditions. The probability that
traces are different due to chance is calculated by the largest vertical separation between pairs of traces using
the Kolmogorov-Smirnovmethod. C, PDFs of the homodimerization of the truncationALDPmutants ALDP390
(orange trace, n 13 cells), ALDP550 (yellow trace, n 9), ALDP551–657 (gray trace, n 7), ALDPNBF (pink
trace, n  9), and ALDP658 (green trace, n  11). The corresponding CDFs are shown in D using the same
color-coding. E, probability of exceeding the threshold FRET ratio for the negative control ALDP-Pex26 was
determined for each cell in every condition and is represented in the bar graph as average  S.E. Statistical
significance of deviation from the ALDP-Pex26 interaction is indicated: **, significant at the 5% level; *, signif-
icant at the 10% level. Kolmogorov-Smirnov testing was used to test the statistical significance of pair-wise
differences between conditions at the 1% level. Red brackets show the conditions in panels A and C that are
statistically indistinguishable. All other conditions within the panels A and C are statistically different.
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corresponding cumulative normalized distributions for these
conditions are shown in panel A. In this analysis, only the con-
dition ALDP/ALDP contains significantly higher FRET than
the ALDP/Pex26 control. Nevertheless, the cumulative histo-
grams also show a clear shift of the peak FRET ratio to higher
values, taking an intermediate position between the ALDP/
Pex26 control and the ALDP/ALDP homodimerization. The
FRET probability method is not sensitive toward changes in
distribution below the FRET threshold. Clearly, the choice for
the threshold point at the high value of three times the standard
deviation eliminates the differences that would have been reg-
istered for a lower threshold value. Therefore, the cumulative
distributions were subjected to a second analysis using Kol-
mogorov-Smirnov (KS) statistics (37). The integrated PDFs for
these conditions are shown in panel B of Fig. 3. These curves,
known as cumulative density functions (CDFs), provide a
robust estimator for distribution similarity or dissimilarity.
Visually, coinciding CDFs indicate statistically identical condi-
tions, larger separations indicate statistically significant differ-
ences. All conditions are statistically different at very low con-
fidence levels (even lower than 1‰). Consequently, the
interactions seen between ALDPwith PMP70 and PMP70 with
PMP70 are less pronounced than the one for ALDP with itself;
nevertheless, they are relevant. KS testing returns the latter two
conditions to be statistically indistinguishable from each other
(red bracket in panel E). We determined an expression level for
PMP70-CFP of 0.5 times the amount of endogenous cellular
PMP70 in 21 cells (S.E. 0.1) and a 6.6-fold overexpression of
CFP-ALDP (S.E.  0.9 in 16 cells). These findings indicate a
lower detection sensitivity for PMP70 homodimers and
PMP70-ALDP heterodimers than for ALDP homodimers.
Protein-Protein Interaction of ALDP Deletion Constructs—
Because ALDP can dimerize in the peroxisomal membrane,
preferentially forming homodimers, we went on to identify the
protein domains thatmediate these interactions. Detailed anal-
ysis for the interaction of ALDP
mutant forms with the required
high sensitivity was possible since
FRET for homodimerization of wild
type ALDP had revealed a very high
efficiency. We generated various
truncation mutants that lacked
defined C-terminal cytoplasmic
sequences including motifs like
Walker A, Walker B, and the
19-mer sequence of the nucleotide
binding fold (Fig. 1).We transfected
cells with mutant ALDP-EYFP and
co-expressed mutant ALDP-ECFP.
Again, proper peroxisomal localiza-
tion of the truncated fluorescence-
tagged proteins was verified by
co-transfection of each construct
with the established peroxisomal
marker ECFP-SKL or EYFP-SKL.
The upper panel of Fig. 4 shows the
peroxisomal localization 20–24 h
after transfection of the YFP-conju-
gated partner for each pair of identical truncationmutants that
were co-expressed. The lower panel illustrates the correspond-
ing FRET ratios in the same scale and false color table as already
shown in Fig. 2.
The mutant ALDP390 carries the largest cytoplasmic dele-
tion covering amino acids 1–390 followed by the fluorescent
proteins ECFP or EYFP (Fig. 1). ALDP390 almost exclusively
contains the N-terminal half with all six transmembrane
domains, but completely misses the nucleotide binding fold.
This mutant allowed us to ask whether the N-terminal half of
ALDP is necessary and sufficient for homodimerization. Vero
cells co-expressing ALDP390-ECFP and ALDP390-EYFP
showed weak FRET (Fig. 4, left panel) that was significantly
lower than for the homodimerization of full-length ALDP (Fig.
2) but only slightly lower than for the heterodimerization of
full-length ALDP with PMP70 (Fig. 2). Quantitative analysis
using both 3- and KS statistical tests (Fig. 3, C–E) confirms
this interpretation over multiple cells (n  13). Statistical sig-
nificance is reached at the 1% confidence level by the sensitive
KS test.
Next, we used longer versions of mutant ALDP, namely
ALDP550 andALDP658. ALDP550 consists of amino acids 1 to
550 followed by either ECFP or EYFP (Fig. 1); this contains all
transmembrane domains and theWalker A motif of the nucle-
otide binding fold. The obtained FRET ratio is slightly higher
when compared with mutant ALDP390 (Fig. 3) over multiple
cells (n 9). It is statistically higher than for the ALDP/Pex26
control (5% confidence level in the 3- test, 1% in KS) but
indistinguishable from the PMP70/ALDP association (KS 
1.4%). ALDP658 contains amino acids 1–658 followed by ECFP
or EYFP (Fig. 1); this includes all six transmembrane domains
and also Walker A, Walker B, and the 19-mer sequence of the
nucleotide binding fold. The obtained FRET ratios are in
between those formutantALDP390 andmutantALDP550over
FIGURE 4. Homodimerization of truncated ALDP proteins. The upper panel shows the fluorescence distri-
bution of YFP-labeled truncated ALDP proteins in peroxisomes of cells co-expressing the same CFP-labeled
ALDP truncation mutants. Homodimerization of these ALDP truncation mutants was assessed by FRET. Their
FRET ratios are presented as described in the legend to Fig. 2.
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multiple cells (n  11) (Fig. 3) and are statistically identical to
the values found for the PMP70/ALDP interaction (KS 65%).
Thus, all C-terminal-truncated ALDP mutant constructs
exhibit intermediate FRET values. They are lower than FRET
values obtained for homodimerization of full-lengthALDP, but
do not reach the low FRET levels exhibited by the negative
ALDP/Pex26 control. Because the extreme C terminus (amino
acids 658–745) is absent in all three ALDPmutants, we assume
that this protein domain influences the efficiency of the pro-
tein-protein interactions. Therefore, we fused amino acids
658–745 to the truncation mutant ALDP550 (Fig. 1). This
mutant protein contains all six transmembrane domains, the
Walker Amotif of the nucleotide-binding fold and the extreme
C terminus (amino acids 658–745). Co-expression of
ALDP551–657-ECFP/ALDP551–657-EYFP resulted in
high FRET values (Fig. 3) even surpassing the FRET levels
observed in the full-length ALDP homodimerization. Both sta-
tistical tests over multiple cells (n  7) revealed highly signifi-
cant statistical differences with full-length ALDP. The last con-
struct, ALDPNBF, lacks the complete NBF (Fig. 1). We fused
the C-terminal amino acids 658–745 to the truncation mutant
ALDP390 resulting in a mutant that includes all six transmem-
brane domains and the extreme C terminus. After transfection
the ALDPNBF construct shows strong FRET with an overall
ratio of 0.25 (Fig. 4, right panel) comparable with full-length
ALDP. These results are supported by 3- and KS statistical
tests over multiple cells (n  9) (Fig. 3, C–E). They provide
evidence that the extreme C-terminal part plays an important
role in ALDP homodimerization and further that the nucleo-
tide binding fold is not required.
DISCUSSION
Mutations in the gene encoding the peroxisomal membrane
protein ALDP cause X-ALD, fromwhich the protein derives its
name (1, 8). X-ALD is a debilitating disease that can already
manifest in early childhood and is caused by the loss or dereg-
ulation of the biological function of ALDP. ALDP is a member
of the ABC transporters that most likely mediates the translo-
cation of activated fatty acids or fatty acid substrates for catab-
olism by peroxisomal matrix enzymes (13, 14). A detailed
understanding of the mode of operation and interaction of this
class of proteins in the peroxisomal membrane is therefore
important to arrive at the understanding of their molecular
mechanism. Investigations using yeast two-hybrid assays and
co-immunoprecipitation experiments revealed that human
ALDP either forms homodimers or heterodimers with PMP70
and ALDR (28, 29, 30). In contrast, investigations using immu-
noprecipitated ALDP and PMP70 complexes from digitonin-
solubilized mouse liver peroxisomes came to the conclusion
that ALDP as well as PMP70 can only homodimerize and not
heterodimerize (31). The variable, sometimes even contradict-
ing reports on the interaction of peroxisomal ABC transporters
in the literature are likely the result of differences in experimen-
tal procedures that suffer from the problems of biochemical
analysis of transmembrane proteins where protein-protein
interactionsmight be disrupted by solubilization procedures or
the solubilization of membrane proteins might be incomplete
leading to co-immunoprecipitation of proteins that just reside
in the same membrane fragment rather than interacting with
the protein of interest.
To circumvent these difficulties and limitations, we decided
to investigate protein-protein interactions of ALDP in intact
living cells and applied in vivoFRETmicroscopy. This approach
makes it possible for us to compare different interactions in
native peroxisomal membrane in the presence of all accessory
proteins that safeguard adequate protein folding. The absence
of FRET in the negative biological control ALDP/Pex26 shows
that the overexpression of fluorescently labeledABC transport-
ers in Vero cells does not drive artificial interactions. This
excludes a molecular crowding effect in the peroxisomal mem-
brane, which could result in false positive FRET signals. Using
live cell FRET microscopy, we were able to detect the co-exist-
ence of homomeric interactions of ALDP and PMP70, and het-
erodimeric interactions between ALDP and PMP70. Our
observations are in good agreement with the data of other
groups. Liu et al. (28) showed homo- as well as heterodimeriza-
tion of ALDP, PMP70 and ALDR by co-immunoprecipitation
experiments and yeast two-hybrid assays. In contrast to our
experimental approach, they expressed proteins that lack the
transmembrane domain. Smith et al. (29) published similar
data, also showing homodimerization and heterodimerization
ofALDPwithPMP70 andALDRby co-immunoprecipitation of
ABC transporters synthesized by a coupled in vitro transcrip-
tion/translation system. Tanaka et al. (30) demonstrated the
interaction of ALDP and PMP70 together with other, as yet,
unidentified proteins by immunoprecipitation of rat liver per-
oxisomes after incubation with 8-azido-[-32P]ATP. Intrigu-
ingly,Wouters et al. (38) unexpectedly detected FRET between
the peroxisomal matrix protein nonspecific lipid transfer pro-
tein (nsL-TP, also called sterol carrier protein 2, SCP2) and the
ABC transporter PMP70, which was originally included as a
negative control. This result was ascribed to a possible crowd-
ing effect at the membrane interface and not further investi-
gated. In retrospect, the later verification of nsL-TP as a fatty
acid carrier with a proposed role in substrate shuttling to and
between peroxisomal -oxidation pathways (39, 40) renders
complex formation with PMP70 relevant. PEX26, our expres-
sion control lends credit to this possible role as we could
exclude a crowding effect even inside themembrane and at high
CMV-driven expression levels.
We are the first to show that the in vitro proposed homo- and
heterodimerizations of ALDP and PMP70 also occur in vivo.
The FRET values for the homodimerization of ALDP are higher
than for PMP70 homodimerization and ALDP/PMP70 het-
erodimerization. ALDP heterodimerization returned FRET
values that were statistically indistinguishable from those for
PMP70 homodimerization. Taking into account the lower rel-
ative overexpression levels for PMP70 when compared with
ALDP, it has to be noticed that the actual FRET values for
PMP70 homodimerization and PMP70-ALDP heterodimeriza-
tion are underestimated. This is mainly caused by the large
fraction of unlabeled endogenous PMP70 that competes with
CFP-labeled PMP70 for the binding of YFP-tagged acceptor
protein and thus reducing the observed effective FRET signal.
These findings support and complement the results of Guima-
ra˜es et al. (31) who found homomeric interactions of ALDP and
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PMP70 in digitonin-solubilized peroxisomal protein prepara-
tions, but failed to detect their heterodimers. Thismight be due
to the high abundance of PMP70 andALDP homodimers in the
peroxisomal membrane which makes it difficult to detect the
lower abundant ALDP-PMP70 heterodimers. Our data conclu-
sively show the existence ofALDP/PMP70heterodimers along-
side their respective homodimers. Formation of heterodimers
allows the regulation of transport of different cargo substances.
In Drosophila, the uptake of precursors for the synthesis of red
and brown pigments that determines eye color is controlled by
various combinations of the ABC half-transporters scarlet,
brown, and white, resulting in different substrate specificities
(41). Analogously, the heterodimerization of ALDP with other
peroxisomal ABC transporters might allow the transport of
fatty acids of different chain lengths (e.g. very long chain fatty
acids, long chain fatty acids) or classes (un/saturated fatty acids,
branched chain fatty acids) or even substrates for peroxisomal
-oxidation.
Our FRET experiments with the ALDP deletion mutants
demonstrate an important role of the last 87 C-terminal amino
acids (amino acids 658–745) for homodimerization. In con-
trast, the nucleotide-binding fold is not necessary and sufficient
for homodimerization as can be seen from the ALDPNBF
construct. This is consistent with the data of Liu et al. (28) who
showed that ALDP amino acids 361–745 are sufficient for
ALDP interaction in the yeast two-hybrid assay as well as with
the data of Roerig et al.who showed that the nucleotide binding
fold is not involved in ALDP dimerization (42). In contrast to
these previous studies, our deletion proteins were expressed
including all six transmembrane domains. We were able to
show that deletion of the complete C-terminal protein part did
not fully prevent ALDP/ALDP interaction, as judged by the
statistically significant residual FRET values. This strongly sug-
gests that the transmembrane domains perform an accessory
role in the stabilization of homomers.
Mutations that are causative for X-ALD occur throughout
the entire ALD gene. In exon 10, encoding the last 81 C-termi-
nal amino acids, to date just two mutations have been found,
suggesting that this exon is of functional importance. However,
Smith et al. (29) found that this exon has no influence on the
functionality of ALDP. They transfected fibroblasts from an
X-ALD patient (A626T) with an ALDP construct carrying a
myc epitope replacing amino acids 693–745. This construct
restored the levels of VLCFA -oxidation to the same extent as
wild-type ALDP. We cannot exclude the possibility that the
C-terminal amino acids permit homodimerization by exerting
a structurally stabilizing activity on the remaining fragments of
the ALDP protein. In this light, either the remaining 30 AA of
exon 10 or theMyc epitope or both are sufficient to restore the
stability of the truncated ALDP protein. However, on the basis
of our findings, we suggest that the transmembrane regions
play a role in mediating or stabilizing protein interaction.
Approximately 10% of X-ALD kindred share a mutation that
leads to a premature Stop codon at amino acid position 554.
The mutation involves the deletion of AG at cDNA position
1415–1416 leading to a frameshift from amino acid residue
Glu471 (fsE471). This protein lacks a functional nucleotide
binding fold and is unstable and inactive (43). This suggests that
stabilization of homomeric interaction by the transmembrane
domain itself is not sufficient for protein stability and supports
the critical role of the C-terminal part for optimal protein-pro-
tein interaction. Our data are also consistent with this conclu-
sion as ALDP551–657 and ALDPNBF display very high
FRET intensities. In fact, these values reach or exceed those
obtained for the full-length protein, suggesting that the inter-
action is slightlymoderated by intrinsic destabilizing structures
in this deletion domain.
In conclusion, our analytical in vivo approach performed in
intact living cells expressing fluorescently labeled forms of the
ABC transporters ALDP and PMP70 as well as truncation
mutants of ALDP, has allowed us to confirm and consolidate
previous reports on their interaction. Our findings extend
beyond the verification of these interactions in a physiologically
relevant setting in that they allowed the elucidation of hitherto
unknown mechanistic aspects that bear direct relevance to the
understanding of the mechanism of action of this class of pro-
teins and the related human pathology: ALDP homodimers,
PMP70 homodimers, and ALDP/PMP70 heterodimers exist in
the peroxisomal membrane and ALDP homodimers are stabi-
lized by their transmembrane domains.
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